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A conference presented by the IBA Intellectual Property and Entertainment  
Committee and the IBA Technology Law Committee, supported by the  
IBA Closely Held and Growing Business Enterprises Committee and the  
IBA Healthcare and Life Sciences Law Committee
6th Annual World  
Life Sciences 
Conference
1–2 June 2018, InterContinental Boston 
Boston, Massachusetts, USA
This year’s event will feature a dynamic roundtable session, as well as concurrent 
sessions covering the hottest topics and the latest developments from across the 
different sectors of the Life Sciences Industry. 
Topics include: 
• Recent trends and future of Life Sciences
• Artificial intelligence and other technologies in the Life Sciences
• Blockchain, health data and privacy
• Recent developments in the Life Sciences patent litigation
• The complex net of relationships and collaborations in the global Life Sciences
• New trends and rules on interactions with HCPs
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Programme
Conference Co-Chairs
Özge Atılgan Karakulak Gün + Partners, Istanbul; Vice Chair, 
IBA Intellectual Property and Entertainment Law Committee 
Alejandro Luna Olivares & Cia, Mexico City; Chair, Patent Law 
Subcommittee, IBA Intellectual Property and Entertainment Law 
Committee
Executive Committee
Gustavo Alcocer Olivares & Cia, Mexico City
Patricia Hoet-Limbourg Hoet Pelaez Castillo & Duque, Caracas; 
Council Member, IBA Legal Practice Division
Yuval Horn Horn & Co, Tel Aviv
Jason Jardine Knobbe Martens, San Diego; Vice Chair, 
Emerging Intellectual Property Rights Subcommittee,  
IBA Intellectual Property & Entertainment Law Committee
Rich Kelly Mintz Levin, Boston; Website Officer,  
IBA Closely Held and Growing Business Enterprises Committee
Local Host Committee
Burns & Levinson
Choate Hall & Stewart
Foley Hoag
Knobbe Martens
McDermott Will & Emery 
Mintz Levin
Nixon Peabody
Supporting Committee
Lorenza Ferrari Hofer Pestalozzi Attorney at Law, Zurich
Hector Jausas Jausas Legal, Barcelona
Catherine Longeval Van Bael & Bellis, Brussels; Conference 
Quality Officer, IBA Healthcare and Life Sciences Law Committee
Teresa Paz-Ares Uría Menéndez, Madrid; Vice Chair, Corporate 
Information Governance Subcommittee, IBA Technology Law 
Committee
Stephan Rau McDermott Will & Emery, Munich; Co-Chair,  
IBA Healthcare and Life Sciences Law Committee
Anderson Ribeiro Kasznar Leonardos, São Paulo
Christophe Ronse Altius, Brussels; Chair, IBA Life Sciences 
Subcommittee, IBA Technology Law Committee
Cécile Théard-Jallu De Gaulle Fleurance & Associés, Paris; 
Website Officer, IBA Healthcare and Life Sciences Committee
Steve Weiner Mintz Levin, Boston; Senior Vice Chair,  
IBA Healthcare and Life Sciences Law Committee
Thursday 31 May
1830 – 2030 Reception provided by local Host Committee 
Barking Crab
88 Sleeper St, Boston, MA 02210, USA
The venue is located five minute’s walk from the InterContinental 
Boston.
The reception is open to all registered delegates.
Headline social event sponsor Conference dinner sponsors
Friday 1 June

0730 – 1730 Registration
0730 – 0830 Continental breakfast
0830 – 0840 Opening remarks by Conference Co-Chair
Özge Atılgan Karakulak Gün + Partners, Istanbul; Vice Chair, 
IBA Intellectual Property and Entertainment Law Committee 
0840 – 0900 Keynote presentation
Blockchain in the Life Sciences: lessons learned 
thus far 
Speaker
Dr John D Halamka MD Editor in Chief of ‘Blockchain in 
Healthcare Today’, CIO of BIDMC (Beth Israel Deaconess Medical 
Center), Boston, Massachusetts
0900 – 0930
Interview on stage with Tina Chappell of Intel 
on intersection of artificial intelligence and other 
technologies in the Life Sciences
Interviewer
Corey Salsberg Novartis, Washington DC
0930 – 1230 Roundtables 
Introduction
Yuval Horn Horn & Co, Tel Aviv
Topic one
Off-label uses of medicines 
In the wake of an increasing amount of off-label uses and 
recommendations, the following paramount questions arise: Can 
the importance of a marketing authorisation be disregarded, 
mostly for cost-related issues? Is off-label a relevant comparator 
from the pricing and reimbursement perspective? Can a product 
used off-label be considered as a competitor for purposes of 
market definition? What other implications are there from the 
regulatory, commercial and antitrust angle? 
Co-Moderators
Natalia Castro Raisbeck & Castro, Bogotá
Torrey Cope Sidley Austin, Washington DC
Helen Waxberg Mannheimer Swartling, Stockholm
Topic two
Robotic surgery 
A developing number of healthcare centres and practitioners are 
digitalising their day-to-day practices and rebuilding the patient 
pathway around more and more remote medical care. Where are 
we standing today from a legal perspective?
Moderator
Victor Song Auris Surgical Robotics, Redwood City, California
Topic three
Developing a global patent strategy for a med 
device start up 
This round table will address how to balance protection and cost 
with a view toward blocking competitors in relevant markets 
and potential patent litigation. Discussion may address searching 
(how much and when), filing of provisional applications first 
in the US or elsewhere, where to file national applications, 
differences in patent eligibility requirements between countries, 
preparing for or conducting IP diligence for acquisition, specific 
patent office programs to expedite and improve examination, 
freedom to-operate studies and competitor monitoring, and 
selection of counsel.
Co-Moderators
Anna Valborg Guðmundsdóttir Össur, Reykjavik 
Tatjana Latinovic Össur, Reykjavik 
Sabing Lee Knobbe Martens, Irvine, California
Topic four
Regulations affecting new and alternatives 
treatments for cancer 
This table will address current and future regulations in different 
countries for new cancer treatments, with special attention to the 
world’s first genetically engineered immune therapy regarding the 
T-cell treatment. 
Co-Moderators
Joaquín Núñez Hoet Pelaez Castillo & Duque (HPCD), Caracas
Corey Salsberg Novartis, Washington DC 
Conference luncheon sponsors
Friday continued
Topic five
Parallel trade: genuine vs artificial parallel trade
Genuine parallel trade is the natural consequence of price 
differentials in the relevant markets, provided that they arise from 
the market operators’ freedom to set prices. Artificial parallel 
trade is a form of arbitrage that derives from the price differences 
provoked by governmental coercive price controlling. What are 
the legitimate pricing and supply schemes that could be put in 
place by pharma companies in order to avoid undesirable flows of 
products from low-price countries into high-price countries?
Co-Moderators
Eduardo Hallak Licks Attorneys, São Paulo 
Stephanie Pautke Commeo, Frankfurt; Committee Liaison 
Officer, IBA Healthcare and Life Sciences Law Committee 
Teresa Paz-Ares Uría Menéndez, Madrid; Vice Chair, Corporate 
Information Governance Subcommittee, IBA Technology Law 
Committee 
Topic six
Gene editing and CRISPR Cas9 
Gene-editing technologies, such as CRISPR-Cas9, are all the rage. 
But what are they? What are the potential benefits and risks? How 
are these technologies being regulated and commercialised? What 
are the patent issues? We will discuss these questions and more.
Co-Moderators
Kevin M Esvelt MIT Media Lab, Cambridge, Massachusetts
Alexander Spiegler Arent Fox, Washington DC
Topic seven
International treaties and their impact on the Life 
Sciences industry
Although there are some voices against, including some leaders 
of the highest industrialised countries in the world, globalisation 
in all aspects of trade and commerce is now a non-stoppable 
trend. Globalisation is materialised in new and innovative manners 
to connect and make business across the borders but also in 
bilateral and multilateral free trade agreements. Some examples 
are taking place around the world such as the Comprehensive 
and Progressive Agreement for Trans-Pacific Partnership (CPTPP) 
signed in Chile in March 2018, where 11 countries agreed in 
the most ambitious free trade agreement ever signed. There are 
other examples around the world of renegotiations of free trade 
agreements which surely will impact the Life Sciences industry 
from the business and legal frame standpoints, situation which 
will be discussed taking advantage of the various jurisdictions 
represented in this conference. 
Co-Moderators
Sajai Singh J Sagar Associates, Bengaluru; Vice Chair,  
IBA Technology Law Committee 
Yuri Vázquez Krasowsky Director of Intellectual Property, the 
Mexican Association of Pharmaceutical Research Industries (AMIIF), 
Mexico City
Topic eight
Reproductive issues and the law
This table will discuss how new reproductive technologies are 
being treated in the law in both Europe and the US, as well as 
some recent decisions at the EPO/USPTO. Participants will discuss 
what is done in their country and what do they feel is the right 
approach.
Co-Moderators
Lorenza Ferrari Hofer Pestalozzi Attorneys at Law, Zurich
Jason Jardine Knobbe Martens, San Diego, California; Vice 
Chair Emerging Intellectual Property Rights Subcommittee, IBA 
Intellectual Property & Entertainment Law Committee
Topic nine
Innovation hub
Can collaboration and an open innovation atmosphere be the way 
to go for Life Science companies to gain competitive advantages? 
During recent years we have seen more and more interaction 
between emerging biotech/medtech companies, academic groups 
and big pharma in different innovation hubs’ set-ups. But, what 
are the key issues for a win-win set up of an innovation hub and 
what’s up and coming on the innovation hub sky? What are the 
challenges, and can these challenges be turned into something 
positive for all parties?
Co-Moderators
Dr Magnus Björsne AstraZeneca, BioVentureHub, Gothenburg
Caroline Ygge Morrislaw, Gothenburg; Vice Chair, Disputes and 
Rights Subcommittee, IBA Technology Law Committee
Topic ten
Reverse mergers of Life Sciences companies
The IPO market for Life Sciences companies in recent years 
has been slow. In order to facilitate financing such companies, 
many have opted to reverse merge into publicly traded shells. 
Such transactions enable early stage companies which would 
have otherwise not been able to file a prospectus, to become 
publicly traded entities and attract the public and other, non-
venture capital related, investors. The round table will enable 
the participants to discuss the key issues and lessons learned in 
structuring, evaluating and negotiating reverse mergers, and the 
reality of becoming a publicly traded company at an early stage.  
Kindly supported byExhibitors
Friday continued
Co-Moderators
Marc D Mantell Mintz Levin, Boston, Massachusetts
Rick Pierce FEP Capital Advisors, Cambridge, Massachusetts
1230 – 1330 Lunch
1330 – 1430 
Health data privacy: How the GDPR will impact 
EU and US health care Providers?
While it reinforces or creates new individual rights, the GDPR 
obliges public or private actors to take far reaching technical and 
organisational data protection measures to become compliant 
following a new self-accountability approach. Beyond the rules now 
shared by a majority of players at an international level, a series of 
topics have been left for EU member States to possibly add conditions 
and limitations to the GDPR. Health data and scientific research are 
part of this subsidiary mechanism. Let’s focus on the main features 
of the GDPR on the processing of health data and how it is now 
implemented in main economic places around the world. 
Co-Moderators
Leticia López-Lapuente Uria Menendez, Madrid 
Cécile Théard-Jallu De Gaulle Fleurance & Associés, Paris; 
Website Officer, IBA Healthcare and Life Sciences Committee
Speakers
Florence Eon General Counsel of the Shared Healthcare 
Information Systems Agency, ASIP Santé, Paris
Professor Federico de Montalvo Universidad Pontificia Comillas 
and UNESCO, Madrid 
Julia Hesse Choate Hall & Stewart, Boston, Massachusetts
1430 – 1530
Digital health – hospital of the future
The use and adoption of telemedicine in various forms is 
becoming common. Hospitals of the future will depend on 
increased computer power and use of digital means in order to 
provide and monitor the caregiving process. The panel will bring 
together experts in the legal analysis of telemedicine in order to 
take a close look at the legal matters that are currently being dealt 
with by practitioners and medical institutions.
Co-Moderators
Yuval Horn Horn & Co, Tel Aviv
Dale Van Demark McDermott Will and Emery, Washington DC; 
Vice Chair, Intrusive Technologies Subcommittee, IBA Technology 
Law Committee 
Panellists 
Mitchell Goldburgh NTT Data (formerly Dell Services), 
Southbury, Connecticut
Jackie Haydock Microsoft, Minneapolis, Minnesota
Christopher Kirby Deputy General Counsel, Boston Children’s 
Hospital, Boston, Massachusetts
1530 – 1550 Coffee/tea break
1550 – 1650
Biosimilars
• Choreographing US and European biosimilar dances
• New developments on patenting
• Similarity and interchangeability, Biosimilars
• Bio-betters and Bio-worse 
What is the fuss all about and why should we care?
Co-Moderators
Martin Draebye Gantzhorn Bech-Bruun, Copenhagen 
Otto Licks Licks Attorneys, Rio de Janeiro
Panellists
Cinthia Ambrogi Country Legal Head, General Counsel, Sanofi, 
São Paulo
Dr Timo Minssen Professor of Life Sciences & Health Innovation 
Law, Director of the Centre for Advanced Studies in Biomedical 
Innovation Law (CeBIL), University of Copenhagen, Copenhagen 
Julia Pike US Head of Intellectual Property, Sandoz, Princeton, 
New Jersey
Ameet Sarpatwari Instructor in Medicine, Harvard Medical 
School, Boston, Massachusetts
1650 – 1730
Marijuana technology for medical purposes
As the research of therapeutic effects of marijuana moves forward, 
the list of the countries that have legalised marijuana as an 
ingredient for formulations to be authorised keeps growing. On 
the other hand, there are those countries where the prohibition 
is very strict and the possibility to have marijuana legalised for 
medical uses seems very far; however, does such prohibition limit a 
human right to health?
Moderator
Emily Leongini Arent Fox, Washington DC
Panellists
Carlos Jesús Yadir Lizardi Álvarez Head of the Legal 
Department of The Mexican Regulatory Agency, COFEPRIS,  
Mexico City
Alice Mead Greenwich Biosciences, Carlsbad, California 
1900 – 2130 Conference Dinner
Oak+Rowan
321 A St, Boston, MA 02210, USA
Ticket price: US$130
Transport will not be provided. 
Drinks reception sponsors (Host committee)
Saturday 2 June
0800 – 1200 Registration
0800 – 0830 Continental breakfast
0830 – 0940 First concurrent sessions 
IP litigation
This panel will discuss recent patent litigation trends affecting 
biotech and pharma industries worldwide. We will discuss recent 
changes in the patent litigation landscape in different jurisdictions, 
and how those changes specifically affect the pharmaceutical 
and biotech industries. How have post-grant patent office 
proceedings affected patent litigation in various jurisdictions? Have 
recent changes in patent (case-)law led to increased or reduced 
harmonisation? How do patent eligibility standards in various 
jurisdictions affect patenting in the diagnostic, personalised 
medicine, and health technology fields?  
Co-Moderators
Christophe Ronse Altius, Brussels; Chair, IBA Life Sciences 
Subcommittee, IBA Technology Law Committee
Jeff Vockrodt Arent Fox, New York
Panellists
Raúl Heredia Schulenburg Celgene, Summit, New Jersey 
Hans Sauer BIO, Deputy General Counsel for Intellectual Property, 
Washington DC
Hot topics in venture capital investments
Boston is one of the three leading hubs in Life Sciences 
investments. This panel will take advantage of the Boston location 
representatives of leading Boston based funds, and its experienced 
practitioners, in order to discuss the current hot topics, the 
lack of significant venture capital investments in medical device 
companies, the pros and cons of proximity to the leading medical 
institutions and the inevitable comparison to the alternative means 
of funding. 
Co-Moderators
Sharon Gazit Goldfarb Seligman, Tel Aviv; Senior Vice Chair,  
IBA Healthcare and Life Sciences Committee
Matthias Nordmann SKW Schwarz, Munich
Panellists
Frank Silva Principle, Boston Millennia Partners, Boston, 
Massachusetts
Albert Sokol McDermott Will & Emery, Boston, Massachusetts
Wei Zhang Healthcare Investor and Entrepreneur, Boston
0940 – 1050 Second concurrent sessions
Social media advertising
The power of social media is no longer an enigma, as it has 
certainly changed the way businesses communicate and market 
to their audience. The added layer of complexity and uncertainty 
raise the question on how to approach this evolving topic. This 
panel intends to explore the existing guides and case studies from 
the Life Sciences industries to show how to develop social media 
policies to use it as a business advantage, and not a risk element.
Co-Moderators
Héctor Jausas Jausas, Barcelona 
Anderson Ribeiro Kasznar Leonardos, São Paulo
Panellists
Kyle Faget Foley & Lardner, Boston, Massachusetts
Alfredo Sedano EISAI, Mexico City 
Tineke Van Hooland ABBVIE, Wavre
Deal killing diligence issues in medical devices
The panel will focus on specific issues that are challenging and can 
change the direction, or even ‘kill’ the deal.
Moderator
Monika Gattiker Lanter, Zurich; European Regional Forum 
Liaison Officer, IBA Healthcare and Life Sciences Law Committee
Panellists
Douglas Farquhar Hyman, Phelps & McNamara, Washington DC
Bethany Hills Mintz Levin, New York
Phillip Schmidt Zimmer Biomet, Winterthur, Zurich
Karen Weaver Healthcare Attorney, Cleveland, Ohio
1050 – 1120 Coffee/tea break
1120 – 1230 Third concurrent sessions 
New trends and rules on interactions with HCPs
Interactions of the industry (pharma & medical devices) with health 
professionals, including the latest regulatory developments and 
enforcement trends in the US, Latam and Europe.
Moderator
Rohan Virginkar Foley & Lardner, Washington DC
Panellists
Nancy Grygiel Amgen, Thousand Oaks, California
Catherine Longeval Van Bael & Bellis, Brussels; Conference 
Quality Officer, IBA Healthcare and Life Sciences Law Committee
Andres Morales Jr Andres Morales Jr PC, Wayland, 
Massachusetts
Biopharmaceutical market: collaboration vs M&A
Biotech deal activity exploded with French drugmaker Sanofi and 
US based Celgene spending a combined total of more than $20bn 
to add new products for hemophilia and cancer to their medicine 
cabinets. What are the market conditions for making these types 
of deals happen? Or should we expect more?
On the other hand collaborations have also been increasingly 
popular, especially in oncology and immunotherapy. How is a 
collaboration different from an outright purchase or license? This 
panel will discuss the pros and cons that have led to this multi 
billion dollar market.
Moderator
Emmanuelle Trombe McDermott Will & Emery, Paris 
Panellists 
Dr Magnus Björsne AstraZeneca, BioVentureHub, Gothenburg
Scott Orchard Johnson & Johnson Innovation, Cambridge, 
Massachusetts
1230 – 1400 Lunch
The IBA, its officers and staff accept no responsibility for any views expressed, presentations or materials produced by delegates or speakers at the Conference.
Saturday continued
1400 – 1800 Social programme – family and guests welcome!
Freedom trail – walk into History
The Freedom Trail Foundation’s most popular tour highlights the 
revolutionary history that took place at 14 of the historic sites of the 
Freedom Trail, including Boston Common, Old North Church, North 
End, Paul Revere’s House, Massachusetts State House, Park Street 
Church, Granary Burying Ground, King’s Chapel, Site of the first 
Public School, Old Corner Bookstore, Old South Meeting House, Old 
State House, site of the Boston Massacre, and Faneuil Hall.
Ticket price: US$20 each
The tour will start at 1445
Please contact Cristina Reyes at creyes@mintz.com for further 
details and to make your social programme reservation. Please 
note that only a reservation confirmed by payment will be 
honoured.
Information
Date
1–2 June 2018
Venue
InterContinental Boston
510 Atlantic Avenue
Boston, MA 02210
Tel: +1 (617) 217 5004
www.intercontinentalboston.com 
Language
All working sessions and conference materials will be in English.
How to register
Register online by 25 May at www.ibanet.org/conferences/conf880.
aspx and make payment by credit card, to avail of the ten per cent 
online registration discount or complete the attached registration form 
and return it to the Conference Department at the IBA together with 
your bank transfer / cheque payment. You should receive emailed 
confirmation of your registration within five days; if you do not please 
contact confs@int-bar.org.
Hard copy registration forms and fees received:
 on or before after 
 20 April 20 April
IBA member US$935 US$1,060
Non-member* US$1,120 US$1,245
Young lawyers (under 30 years) US$700 US$1,245
Academics/judges (full-time) US$700 US$1,245
Public lawyers US$700 US$1,245
Corporate counsel** US$840 US$1,245
Conference dinner US$130 US$130
* By paying the non-member fee, we welcome you as a delegate 
member of the IBA for the year in which this conference is held, which 
entitles you to the following benefits: 
1) Password access to certain parts of the IBA website. 
2) Receipt of IBA E-news and access to online versions of IBA Global Insight.
3) Pay the member rate for any subsequent conference registrations for 
this calendar year.
** A reduced rate is offered to IBA Corporate Group Members. Please 
register online to obtain a 25 per cent discount on the IBA member fee.
Fees
Online registrations received:
 on or before until 
 20 April 25 May
IBA member US$840 US$955
Non-member* US$1,010 US$1,120
Young lawyers (under 30 years) US$630 US$1,120
Academics/judges (full-time) US$630 US$1,120
Public lawyers US$630 US$1,120
Corporate counsel** US$630 US$1,120
Conference dinner US$130 US$130
After 25 May registrations must be received in hard copy at the IBA office.

If you would like to become a full or general member of the IBA, which 
includes membership of one committee or more – and inclusion in and 
access to our membership directory – we encourage you to do so now in 
order to register for this conference at the member rate. Full details of how 
to join can be found at www.ibanet.org. 
A reduced rate is offered to lawyers who are over the age of 65, have been 
an IBA member for more than 20 years and are no longer practising law.
Full payment must be received in order to obtain your Conference 
documentation. 
Fees include:
• Attendance at all working sessions
• Conference materials, including any available speakers’ papers 
submitted to the IBA before 18 May.
• Access to the above conference working materials from the IBA website 
(www.ibanet.org) approximately seven days prior to the conference
• Access to mobile delegate search application 
• Lunch on Friday and Saturday
• Tea and coffee during breaks
• Invitation to hosted Reception on 31 May
Please note that registrations are not transferable.
List of participants
In order for your name to appear in the list of participants, which will be 
distributed at the conference, your registration form must be received by 
25 May at the latest.
Mobile delegate search application
All registered delegates will receive a printed list of participants at the 
conference, however delegates are now also able to use the mobile 
delegate search. This application has been developed to aid networking 
by giving delegates instant access to an up-to-date list of their fellow 
attendees, and comes with the added benefit of a built-in messaging 
service. All registered delegates with an internet or Wi-Fi-enabled device 
will have access, using their IBA username and password. Simply visit: 
m.ibanet.org/conf880 
 
Registration confirmation 
All documentation regarding your attendance at the conference can now 
be obtained from the IBA website. Upon receipt of your payment for the 
conference a confirmation email will be sent containing instructions on 
how to download the documents. Registration confirmation will not be 
distributed by post.
Photography and filming
Certain sessions and/or social functions may be photographed and/or 
filmed and some of this content may be used for future IBA marketing 
materials, member communications, products or services. Should you 
have any concerns with regard to this, or do not wish to be featured in 
any of these materials please contact the IBA Marketing Department at 
ibamarketing@int-bar.org.
Promotional literature
Please note that no individual or organisation may display or distribute 
publicity material or other printed matter during the conference, unless 
by prior arrangement with the IBA. Organisations and companies wishing 
to discuss promotional opportunities should contact the IBA Sponsorship 
Department at andrew.webster-dunn@int-bar.org.
Payment of registration fees
US dollars: by cheque converted at the current rate of exchange and drawn 
on a US bank and in favour of the International Bar Association. Please send 
to: 4th Floor, 10 St Bride Street, London EC4A 4AD, United Kingdom.
OR by bank transfer to the IBA account number: 01286498 (Sort Code 
56-00-03) at the National Westminster Bank, St James’s & Piccadilly 
Branch, 208 Piccadilly, London W1A 2DG, United Kingdom. SWIFT address 
NWBKGB2L, IBAN GB55NWBK60730101286498. Please ensure that a 
copy of the bank transfer details is attached to your registration form.
Pounds sterling: by cheque drawn on a UK bank and in favour of the 
International Bar Association. Please send to: 4th Floor, 10 St Bride Street, 
London EC4A 4AD, United Kingdom.
OR by bank transfer to the IBA account number: 13270222 (Sort Code 56-
00-03) at the National Westminster Bank, St James’s & Piccadilly Branch, 208 
Piccadilly, London W1A 2DG, United Kingdom or SWIFT address NWBKGB2L, 
IBAN GB05NWBK56000313270222. Please ensure that a copy of the 
bank transfer details is attached to your registration form.
Use the exchange rate prevailing at the time of registration
Euro: by cheque or bank draft, drawn on a euro zone bank and 
converted at the current rate of exchange and in favour of the 
International Bar Association 
OR by bank transfer to the IBA bank account number 550/00/06570631 
(Sort Code 56-00-03) at the National Westminster Bank, St James’s & 
Piccadilly Branch, 208 Piccadilly, London W1A 2DG, United Kingdom or 
SWIFT address NWBKGB2L, IBAN GB58NWBK60721106570631. Please 
ensure that a copy of the bank transfer details is attached to your 
registration form.
Use the exchange rate prevailing at the time of registration
Online credit card payments: by Visa, MasterCard or American Express. 
No other cards are accepted. 
PLEASE ENSURE THAT YOUR NAME AND ‘CON880BOSTON’ APPEAR 
ON ANY TRANSFER OR DRAFT.
No deductions or withholdings
All fees payable to us by you in accordance with the terms contained in 
this ‘Information’ section shall be paid free and clear of all deductions or 
withholdings whatsoever.
If any deductions or withholdings are required by law to be made from any 
fees payable to us by you under the terms contained in this ‘Information’ 
section you shall pay such sum as will, after the deduction or withholding 
has been made, leave us with the same amount as we would have been 
entitled to receive in the absence of any such requirement to make a 
deduction or withholding.
If we obtain the benefit of any tax credit or other relief by reference to any 
such deductions or withholdings, then we shall repay to you such amount as, 
after such repayment has been made, will leave us in no worse position than 
we would have been had no such deductions or withholdings been required.
Conference sell-outs
The IBA places its conference in venues of a suitable size for the event; 
however there are times when our conferences may sell out. Should this 
happen, prospective delegates will be informed and a waiting list will 
operate. The waiting list will function on a ‘first come, first served’ basis, 
subject to receiving registered delegate cancellations. The IBA will not be 
liable for any travel or accommodation expenses incurred by an individual 
who travels to the conference without a confirmed place at the event.  
The organisers may at any time, with or without giving notice, in their absolute discretion and without giving any reason, cancel or postpone the conference, change 
its venue or any of the other published particulars, or withdraw any invitation to attend. In any case, neither the organisers nor any of their officers, employees, 
agents, members or representatives shall be liable for any loss, liability, damage or expense suffered or incurred by any person, nor will they return any money paid 
to them in connection with the conference unless they are satisfied not only that the money in question remains under their control but also that the person who 
paid it has been unfairly prejudiced (as to which, decision shall be in their sole and unfettered discretion and, when announced, final and conclusive).
Cancellation of registration
If cancellation is received in writing at the IBA office by 4 May, fees will be 
refunded less a 25 per cent administration charge. Refunds will be made 
minus any monies owed to the IBA.
We regret that no refunds can be made after this date. Registrations 
received after 4 May will not be eligible for any refund of registration fees. 
Please note that NO exception will be made to this policy. Should you have 
difficulties in obtaining your visa and are not able to attend the conference 
this cancellation policy will still apply.
Upon submission of your completed Conference registration form to the 
IBA you are considered “registered” pending payment. Please note that as 
soon as your registration is received the cancellation terms and conditions 
as indicated will apply. 
Provided you have cancelled your registration to attend an IBA conference 
in accordance with the terms of the ‘cancellation of registration’ 
clause included in the ‘Information’ section of the relevant conference 
programme, you must then confirm to us in writing at the IBA office as 
soon as possible but in no event later than one year (12 calendar months) 
from the date of any such conference all necessary details to enable any 
reimbursement owed to you to be paid. We regret that no refunds will be 
made after the date that is one year (12 calendar months) after the date of 
the relevant conference.
Travel arrangements and visas
Participants are responsible for making their own travel arrangements.  
It is recommended that you check your visa requirements with your local 
embassy or consulate. We are unable to dispatch visa invitation 
letters to support your visa application prior to receipt of your 
registration form and full payment of registration fees. 
Please apply for your visa in good time.
Continuing Professional Development/Continuing Legal Education
*The number of CPD/CLE hours available may vary depending on the rules applied by the members’ bar association/law society on time recording criteria.
For conference delegates from jurisdictions where CPD/CLE is mandatory, the IBA will provide a Certificate of Attendance for the conference. Subject to CPD/CLE 
requirements, this can be used by conference delegates to obtain the relevant number of hours’ accreditation. 
A CPD/CLE Certificate of Attendance is available to conference delegates on request. Please ask at the IBA conference registration desk for information on how 
to obtain the certificate.
Hotel accommodation
A limited number of rooms have been reserved at the InterContinental 
Boston for the nights of 31 May – 1 June (inclusive):
InterContinental Boston
510 Atlantic Avenue
Boston, MA 02210
Tel: +1 (617) 217 5004
www.intercontinentalboston.com 
The following rates are per room, per night, excluding breakfast, service 
charges and local taxes.
Deluxe room single/double US$349
Deluxe room triple US$384
Deluxe room quad US$419
To make your reservation
Tel +1 866-378-0533 quoting ‘IBA World Life Sciences’ – to avail of the 
group rate. Or book online using the IBA’s personalised group web page: 
https://book.passkey.com/e/49590514
The hotel requires a valid credit card number to secure your reservation.
Cancellation and no-show policy
Please note that in the event of a cancellation, less than 48 hours prior 
to the arrival date, one night’s room and tax fee cancellation fee may be 
charged to the individual guest’s credit card given at the time of booking.
Please note that in the event of any cancellations or no-shows, rooms 
will be charged to the individual guest’s credit card given at the time of 
booking. Please note that any reservation made after Thursday 10 May 
2018 will be subject to availability and cannot be guaranteed at the special 
IBA rate. As a limited number of rooms have been blocked at the hotel, 
availability cannot be guaranteed once the room block is full.
Delegates are responsible for making accommodation reservations directly 
with the hotel and entering into an agreement with the hotel regarding 
credit card guarantees, cancellation terms and conditions, and room rates 
(should these differ from the special IBA rate). The IBA cannot accept 
responsibility for hotel accommodation disputes between a delegate and 
the hotel.
Unauthorised Accommodation Agents
It has been brought to our attention that there are multiple companies 
contacting past attendees, claiming to represent the IBA, offering 
‘assistance’ with registration and hotel bookings.
They are operating by cold-calling and spamming companies whose 
names have appeared on previous List of Participants, Programmes and 
Sponsorship recognition. The only Accommodation Agent the IBA works 
with is Judy Lane ICS. Judy Lane ICS do not contact delegates on behalf 
of the IBA without delegates making initial contact. Please ignore any 
communication that does not come directly from the IBA or Judy Lane ICS. 
Disabled access
The InterContinental Boston is wheelchair accessible. Please notify us if you 
require special assistance.
Advert space
International Bar Association
the global voice of the legal profession
The International Bar Association (IBA), established in 1947, is the 
world’s leading organisation of international legal practitioners, bar 
associations, law firms and law societies.
The IBA influences the development of international law reform 
and shapes the future of the legal profession throughout the world. 
It has a membership of more than 80,000 individual lawyers and 
more than 190 bar associations and law societies spanning over 
170 countries.
Inspired by the vision of the United Nations, the IBA was founded 
in the same spirit, just before the Universal Declaration of Human 
Rights was proclaimed in 1948.
The IBA covers all practice areas and professional interests, 
providing members with access to leading experts and  
up-to date information, enabling them to better represent their 
clients’ interests.
Through its various committees, fora and task forces, the IBA 
facilitates the exchange of information and views among its 
members as to laws, practices and professional responsibilities 
relating to the practice of law around the globe.
Intellectual Property and Entertainment Law 
Committee overview
The main areas are patents, trade marks, copyright, trade secrets 
and unfair competition. Allied to these are a number of related 
areas including data protection, database protection, privacy, design 
rights, domain names and the like.
In the entertainment law area the key focus is on the creation, 
provision and delivery of content in relation to print, films, 
broadcasts, cable programmes, musical works and sound 
recordings. There is also involvement with media law including 
defamation and privacy and authors’ rights in a more general sense.
Closely Held and Growing Business Enterprises 
Committee overview
The mission of the Closely Held and Growing Business Enterprises 
Committee is to address issues of particular interest to startups, 
owner-managed, closely held and family businesses and their legal 
advisors, and to organisations with ambitions for growth.
Corporate and Social Responsibility Committee 
overview
The IBA Corporate Social Responsibility Committee has as its mission:
• To promote the development of legal skills required to advise 
on subjects of corporate social responsibility, sustainable 
development and social performance, and to facilitate education 
and dialogue among lawyers who practice in this emerging area 
of the law;
• To support the legal profession in developing CSR strategies for 
their internal organisation and their engagement in communities 
and the world; and
• To champion the improved understanding and practical 
implementation of CSR principles in business, government and 
civil society.
Healthcare and Life Sciences Law Committee overview
The Healthcare and Life Sciences Law Committee is rooted in legal 
issues arising within healthcare sectors throughout the world as 
well as affiliated interest areas within the Life Sciences arena. In 
this regard, it is concerned with those fields of science that involve 
the scientific study of living organisms, with a special focus on 
all aspects of healthcare law, including such areas as medicine 
law, intellectual property, biotech, bioethics, regulatory issues and 
scientific developments, on a worldwide basis.
Technology Law Committee overview
The Technology Law Committee of the International Bar Association 
brings together lawyers practising aspects of the law particularly 
relevant to modern technologies. They have in common that 
they deal with developing bodies of law coming to grips with the 
new questions posed by new technologies. The mandate of the 
Technology Law Committee is broad and includes virtually any kind 
of technology.
North American Regional Forum overview
The IBA is the global voice of the legal profession. It offers an 
international perspective on the practice of law, as well as a 
forum for the exchange of expertise, ideas and contacts amongst 
the leading legal practitioners in the world’s major centres of 
finance, trade, investment and commerce. Through its thousands 
of members worldwide, it offers access to specialists of the 
highest calibre from over 100 countries around the world, many 
of whom meet on a regular basis at an annual conference and 
many regional conferences throughout the year. The membership 
and support of more than 200 bar associations from around the 
world, and the IBA’s important work to promote the rule of law 
and human rights, gives it a uniquely authoritative global voice in 
legal affairs and ensures that the work of its many committees has 
a real and lasting impact.
Latin American Regional Forum overview
The Latin American Forum covers all countries in Latin America 
as well as Mexico, Puerto Rico and Spanish-speaking areas of 
the Caribbean. The LAF provides a focus for all activities in the 
region. The group organises sessions at IBA Conferences and in 
particular has been instrumental in ensuring that a Latin American 
perspective is addressed during relevant special sessions. The LAF is 
closely affiliated with the North American Forum as the regions are 
geographically proximate and share many issues.
Contact information
International Bar Association
4th Floor, 10 St Bride Street, London EC4A 4AD, United Kingdom
Tel: +44 (0)20 7842 0090 Fax: +44 (0)20 7842 0091
Email: member@int-bar.org www.ibanet.org
Registration form
6th Annual IBA World Life Sciences Conference
1–2 June 2018, InterContinental Boston, Boston, Massachusetts, USA
Please read the ‘Information’ section before completing this form and return it together with your bank transfer 
or cheque to the Conference Department at the address overleaf.
REGISTER ONLINE AT WWW.IBANET.ORG/CONFERENCES/CONF880.ASPX TO MAKE IMMEDIATE  
AND SECURE PAYMENT BY CREDIT CARD AND OBTAIN A 10 PER CENT DISCOUNT ON THE FEES BELOW
PERSONAL DETAILS (Please attach your business card or write in block capitals)
Title________________ Given name ____________________________________________ Family name _____________________________________________
Name and country to be shown on badge (if different from above) __________________________________________________________________________
IBA Membership number (if applicable) ________________________________________________________________ Date of birth ______________________
Firm/company/organisation_____________________________________________________________________________________________________________
Address ____________________________________________________________________________________________________________________________
_______________________________________________________________________________ Country ____________________________________________
Tel _____________________________________________________________ Fax ________________________________________________________________
Email ______________________________________________________________________________________________________________________________
SPECIAL DIETARY REQUIREMENTS
If you have special dietary requirements, due to allergen intolerances, medical, religious reasons or a life choice, please specify the requirement below.  
The IBA is unable to cater for dietary requirements other than for the above reasons.
 Please tick box if you have allergen intolerances and specify ____________________________________________________________________________
Please state all other dietary requirements clearly, i.e. I am a vegetarian; I do not eat red meat. 
___________________________________________________________________________________________________________________________________
Disclosure of dietary information denotes you have agreed to the IBA sharing this information with relevant third parties who are providing catering on our behalf.
TO OBTAIN A TEN PER CENT DISCOUNT ON THE FEES BELOW,  
PLEASE REGISTER BY 25 MAY ONLINE AT WWW.IBANET.ORG/CONFERENCES/CONF880.ASPX 
IBA MEMBERS CAN REGISTER ONLINE BY 20 APRIL FOR US$840,  
PLEASE SEE ‘INFORMATION’ FOR FURTHER ONLINE REGISTRATION DETAILS.
HARD COPY REGISTRATION FORMS AND FEES RECEIVED: on or before 20 April after 20 April amount payable
IBA member US$935 US$1,060 US$
Non-member* US$1,120 US$1,245 US$
Young lawyers (under 30 years) US$700 US$1,245 US$
Academics/judges (full-time) US$700 US$1,245 US$
Public lawyers US$700 US$1,245 US$
Corporate counsel** US$840 US$1,245 US$
SOCIAL FUNCTION
Friday 1 June, Conference dinner 
Oak + Rowan  I will attend  US$130
Social function ticket reservations are subject to availability and cannot be guaranteed unless payment has been received before 28 June. 
   TOTAL AMOUNT PAYABLE US$ 
*JOIN THE IBA TODAY AND REGISTER FOR THIS CONFERENCE AT THE IBA MEMBER RATE.  
PLEASE FIND THE MEMBERSHIP APPLICATION FORM AT WWW.IBANET.ORG.
**A REDUCED RATE IS OFFERED TO IBA CORPORATE GROUP MEMBERS.  
PLEASE REGISTER ONLINE TO OBTAIN A 25 PER CENT DISCOUNT ON THE IBA MEMBER FEE
A REDUCED RATE IS OFFERED TO LAWYERS WHO ARE OVER THE AGE OF 65, HAVE BEEN AN IBA MEMBER FOR MORE THAN  
20 YEARS AND ARE NO LONGER PRACTISING LAW. PLEASE CONTACT THE IBA OFFICE FOR FURTHER INFORMATION.
FULL PAYMENT MUST BE RECEIVED IN ORDER TO PROCESS YOUR REGISTRATION.  
PLEASE NOTE THAT REGISTRATIONS ARE NOT TRANSFERABLE.
METHODS OF PAYMENT
By credit card
Register online at www.ibanet.org/conferences/conf880.aspx and make immediate and secure payment by credit card
Note: please do not send your credit card details on the registration form or within an email or fax.
By bank transfer and cheque/draft
 Please send me an invoice.
 I enclose a cheque/draft for the total amount payable.
 I have transferred to the IBA bank account the total amount payable and have attached a copy of the bank transfer details.
US dollars: by cheque converted at the current rate of exchange and drawn on a US 
bank and in favour of the International Bar Association. Please send to: 4th Floor, 10 
St Bride Street, London EC4A 4AD, United Kingdom.
OR by bank transfer to the IBA account number: 01286498 (Sort Code 56-
00-03) at the National Westminster Bank, St James’s & Piccadilly Branch, 208 
Piccadilly, London W1A 2DG, United Kingdom. SWIFT address NWBKGB2L, IBAN 
GB55NWBK60730101286498. Please ensure that a copy of the bank transfer 
details is attached to your registration form.
Pounds sterling: by cheque drawn on a UK bank and in favour of the International 
Bar Association. Please send to: 4th Floor, 10 St Bride Street, London EC4A 4AD, 
United Kingdom.
OR by bank transfer to the IBA account number: 13270222 (Sort Code 56-
00-03) at the National Westminster Bank, St James’s & Piccadilly Branch, 208 
Piccadilly, London W1A 2DG, United Kingdom or SWIFT address NWBKGB2L, IBAN 
GB05NWBK56000313270222. Please ensure that a copy of the bank transfer 
details is attached to your registration form.
Use the exchange rate prevailing at the time of registration.
Euro: by cheque or bank draft, drawn on a euro zone bank and converted at the 
current rate of exchange and in favour of the International Bar Association.
OR by bank transfer to the IBA bank account number 550/00/06570631 (Sort Code 
56-00-03) at the National Westminster Bank, St James’s & Piccadilly Branch,  
208 Piccadilly, London W1A 2DG, United Kingdom or SWIFT address NWBKGB2L, 
IBAN GB58NWBK60721106570631. Please ensure that a copy of the bank 
transfer details is attached to your registration form.
Use the exchange rate prevailing at the time of registration.
WHERE DID YOU FIRST HEAR ABOUT THIS CONFERENCE?
 IBA CONFERENCE  OTHER CONFERENCE  DIRECT MAIL  INTERNET  ADVERTISEMENT
 EMAIL  EDITORIAL  RECOMMENDATION  OTHER
Please provide further details, quoting code (if applicable)
___________________________________________________________________________________________________________________________________
___________________________________________________________________________________________________________________________________
The International Bar Association would like to keep in touch with you about relevant news, events, publications and membership. 
You can opt out of receiving information at any time by emailing member@int-bar.org or by logging into My IBA and updating your preferences. 
For further details on how your data is used and stored: www.ibanet.org/web_privacy_policy.aspx 
PLEASE SEND THE COMPLETED FORM TO INTERNATIONAL BAR ASSOCIATION: 
Conference Department
4th Floor, 10 St Bride Street, London EC4A 4AD, United Kingdom
Tel: +44 (0)20 7842 0090 Fax: +44 (0)20 7842 0091 Email: confs@int-bar.org www.ibanet.org
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Knobbe Martens has one of the largest and 
most experienced life sciences IP practice 
in the world.
Knobbe Martens is comprised of over 275 
lawyers and scientists, with over 100 working 
in life science fields. The combination of law 
and deep technical knowledge makes 
Knobbe Martens attorneys uniquely qualified 
to represent a diverse array of clients in a 
broad spectrum of intellectual property 
matters.  The firm is internationally 
recognized across the spectrum of life 
science disciplines and is considered an 
authority on related intellectual property 
issues. More information about the firm can 
be found at www.knobbe.com.        
International Bar Association 
World Life Sciences Conference
Knobbe Martens is a proud sponsor of the
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When failure is
noT an option,
We can lead
the way.
 
•   Complex Business Litigation
•   Patent, Trade Secrets and Trademark Litigation
•   Prosecution | Patent, Trademark, Design and Copyright
•   Counseling and Transactional
•   Technology & Digital Law
•   Policy Making and Government Relations
•   Life Science | Food & Drug
•   Regulatory
•   Antitrust and Competition Law
•   Criminal and Compliance
 
 
 
 
 
 
 
Rio de Janeiro | Sao Paulo | Brasilia | Tokyo
lickslegal.com
info@lickslegal.com
Licks Attorneys is the new benchmark 
for complex litigation. With 150+ 
professionals across its four oices, 
Licks Attorneys can support companies 
of all sizes and technological fields.
Winning is at the core of our practice.

If you’re a life sciences company doing business in Mexico, talk to the law 
firm that regularly combines high-level technical expertise with legal 
muscle. In an environment that is not always predictable, we are widely 
known for our extensive capabilities in life sciences matters — IP, regula-
tory, transactional, and litigation — and for being, as Chambers says, 
“Consistently at the forefront of cutting-edge market developments.”
www.o l ivares .mx    |     Te l : +52 55 5322 3000    |      o l i v l aw@ol ivares .mx
Our lawyers
know the science.
Our scientists know the law.
